David Malka

Inserm — France

Medicine · Health Sciences

71h-index19.8kcitations450works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(125), Pancreatic and Hepatic Oncology Research(112), Cholangiocarcinoma and Gallbladder Cancer Studies(101), Genetic factors in colorectal cancer(71), Hepatocellular Carcinoma Treatment and Prognosis(70)

Publications448 total

Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Nature Reviews Gastroenterology & Hepatology·2025· 4 citedOpen Access
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)
Therapeutic Advances in Medical Oncology·2025Open Access
Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the <scp>SUN</scp> ‐ <scp>CK GERCOR</scp> Phase <scp>II</scp> Trial
Liver International·2025· 4 citedOpen Access
12P ORGANOTREAT-01: A pioneer phase I/II multicenter trial of organoid-driven precision medicine for refractory colorectal cancer
Annals of Oncology·2025· 1 citedOpen Access
Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients
ESMO Gastrointestinal Oncology·2025Open Access
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative
ESMO Open·2025· 2 citedOpen Access
Correction to “New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe” [The Lancet Regional Health – Europe, volume 50, March 2025, 101170]
The Lancet Regional Health - Europe·2025Open Access
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10—Precision Medicine)
ESMO Open·2025· 8 citedOpen Access
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe
The Lancet Regional Health - Europe·2025· 14 citedOpen Access
Pemigatinib-associated toxicity and its management: implications on prognosis in patients with cholangiocarcinoma treated within real-world Italian PEMIREAL and French PEMIBIL cohorts
SSRN Electronic Journal·2025Open Access
60P Baseline characteristics and molecular testing of patients with IDH1-mutated cholangiocarcinoma: Initial results from the phase IIIb ProvIDHe study
Annals of Oncology·2024· 2 citedOpen Access
Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy
European Radiology·2024· 4 cited
Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (<scp>AFEF</scp>)
Liver International·2024· 14 citedOpen Access
Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis
Frontiers in Oncology·2024· 1 citedOpen Access
Nanoliposomal irinotecan in advanced biliary tract cancers
˜The œLancet. Gastroenterology & hepatology·2024· 2 cited
522P Intra-arterial hepatic chemotherapy: Role beyond colorectal cancer?
Annals of Oncology·2024Open Access
291P Tumor biology, treatment patterns, and survival outcomes in young-onset biliary tract cancers
Annals of Oncology·2024Open Access
Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer
The Oncologist·2024Open Access
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)
Cancers·2024Open Access
Management of biliary tract cancers in early‐onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort
Liver International·2024· 6 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

Michel Ducreux(23), Valérie Boige(18), Clarisse Dromain(10), Diane Goèré(10), Dominique Élias(10), Thierry de Baère(7), Thierry Lecomte(6), Jean‐Charles Soria(6), Jean‐Pierre Pignon(6), Pascal Hammel(5), Caroline Robert(5), Sophie Leboulleux(5), Jean‐Yves Scoazec(5), Éric Baudin(5), Julien Taı̈eb(5), Eric Assénat(4), Christelle de la Fouchardière(4), Martin Schlumberger(4), Thomas Aparicio(4), Frédéric Dumont(4)